Skip to content
10-Q

Quarterly Report

Minerva Neurosciences, Inc. NERV

0000950170-25-069780

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 8, 2025 6.99M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $1.95M
Current Liabilities Q1 2025 · Dec 31, 2024 $2.84M
Total Liabilities Q1 2025 · Mar 31, 2025 $61.95M
Total Liabilities Q1 2025 · Dec 31, 2024 $62.84M
Current Assets Q1 2025 · Mar 31, 2025 $17.92M
Current Assets Q1 2025 · Dec 31, 2024 $22.27M
Total Assets Q1 2025 · Mar 31, 2025 $32.8M
Total Assets Q1 2025 · Dec 31, 2024 $37.14M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $21.36M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $34.82M
Shares Diluted Q1 2025 · Mar 31, 2024 7.57M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$6.09M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$36.59M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$28.46M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.13
Eps Basic Q1 2025 · Mar 31, 2024 −$1.13
Sga Expense Q1 2025 · Mar 31, 2024 $2.51M
Rd Expense Q1 2025 · Mar 31, 2024 $4.17M
Net Income Q1 2025 · Mar 31, 2024 −$8.57M
Operating Income Q1 2025 · Mar 31, 2024 −$6.68M